WEED, Inc. acquired Hempirical Genetics LLC from Jeffery Miller for $0.65 million.
July 20, 2022
Share
WEED, Inc. (OTCPK:BUDZ) acquired Hempirical Genetics LLC from Jeffery Miller for $0.65 million on May 2, 2022. The consideration includes 2 million shares of common stock valued at $.25 per share and $250,000 in cash over 4 years. One million shares and $10,000 was paid on signing this agreement. WEED will pay $5,000 each month starting from July 2022 until paying off the note payable to Hempirical of $240,000.
WEED, Inc. (OTCPK:BUDZ) completed the acquisition of Hempirical Genetics LLC from Jeffery Miller on May 2, 2022.
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
WEED, INC. 